SSTR2 and meningioma: Consequently, somatostatin receptor ligands, such as 68Ga‐DOTA‐Tyr3‐octreotide (DOTATOC), 68Ga‐DOTA‐l‐Nal3‐octreotide (DOTANOC), or 68Ga‐DOTA‐D‐Phe1‐Tyr3‐octreotate (DOTATATE) that have high affinity to the SSTR2, were labeled with the positron‐emitting nuclide 68Ga and used to define the meningioma extent, particularly for treatment planning in patients with meningioma [33].